Package 42571-131-29

{"route": ["ORAL"], "spl_id": "41535937-97d5-fb3f-e063-6294a90afa9e", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "upc": ["0342571131609"], "unii": ["99DK7FVK1H"], "rxcui": ["199422"], "spl_set_id": ["fbd628db-4076-4fe0-8323-9cc33ae92e42"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (42571-131-29)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "42571-131-29", "marketing_start_date": "20120522"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (42571-131-60)", "package_ndc": "42571-131-60", "marketing_start_date": "20120522"}], "brand_name": "NEVIRAPINE", "product_id": "42571-131_41535937-97d5-fb3f-e063-6294a90afa9e", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "42571-131", "generic_name": "NEVIRAPINE", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NEVIRAPINE", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "200 mg/1"}], "application_number": "ANDA203080", "marketing_category": "ANDA", "marketing_start_date": "20120522", "listing_expiration_date": "20261231"}